RJA
DIAX

Raymond James & Associates’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Raymond James & Associates’s Portfolio DIAX Stock Details DIAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.32M Sell
88,866
-2,090
-2% -$30K ﹤0.01% 2504
2024
Q2 		$1.27M Sell
90,956
-4,264
-4% -$59.8K ﹤0.01% 2460
2024
Q1 		$1.4M Sell
95,220
-11,387
-11% -$164K ﹤0.01% 2388
2023
Q4 		$1.49M Sell
106,607
-28,453
-21% -$388K ﹤0.01% 2273
2023
Q3 		$1.85M Sell
135,060
-23,792
-15% -$336K ﹤0.01% 2072
2023
Q2 		$2.24M Sell
158,852
-12,935
-8% -$187K ﹤0.01% 1986
2023
Q1 		$2.52M Sell
171,787
-16,168
-9% -$245K ﹤0.01% 1896
2022
Q4 		$2.92M Sell
187,955
-13,010
-6% -$197K ﹤0.01% 1761
2022
Q3 		$2.71M Sell
200,965
-10,270
-5% -$159K ﹤0.01% 1771
2022
Q2 		$3.23M Sell
211,235
-31,540
-13% -$504K ﹤0.01% 1699
2022
Q1 		$4.03M Sell
242,775
-16,168
-6% -$271K ﹤0.01% 1667
2021
Q4 		$4.6M Buy
258,943
+161,601
+166% +$2.82M ﹤0.01% 1608
2021
Q3 		$1.63M Sell
97,342
-39,713
-29% -$685K ﹤0.01% 2239
2021
Q2 		$2.33M Sell
137,055
-13,187
-9% -$222K ﹤0.01% 1988
2021
Q1 		$2.44M Sell
150,242
-18,172
-11% -$279K ﹤0.01% 1877
2020
Q4 		$2.56M Sell
168,414
-23,768
-12% -$340K ﹤0.01% 1753
2020
Q3 		$2.6M Sell
192,182
-28,639
-13% -$395K ﹤0.01% 1596
2020
Q2 		$3M Sell
220,821
-29,971
-12% -$400K ﹤0.01% 1483
2020
Q1 		$3.14M Buy
250,792
+24,525
+11% +$394K 0.01% 1309
2019
Q4 		$4M Buy
226,267
+10,148
+5% +$181K 0.01% 1392
2019
Q3 		$3.85M Buy
216,119
+12,000
+6% +$212K 0.01% 1373
2019
Q2 		$3.6M Sell
204,119
-8,751
-4% -$154K 0.01% 1430
2019
Q1 		$3.83M Sell
212,870
-69,875
-25% -$1.23M 0.01% 1344
2018
Q4 		$4.56M Sell
282,745
-27,823
-9% -$497K 0.01% 1158
2018
Q3 		$6.15M Sell
310,568
-24,329
-7% -$466K 0.01% 1097
2018
Q2 		$6.19M Buy
334,897
+71,538
+27% +$1.35M 0.01% 1064
2018
Q1 		$4.68M Sell
263,359
-98,494
-27% -$1.81M 0.01% 1187
2017
Q4 		$6.82M Buy
361,853
+97,530
+37% +$1.74M 0.01% 961
2017
Q3 		$4.48M Buy
264,323
+22,977
+10% +$383K 0.01% 1146
2017
Q2 		$3.99M Buy
241,346
+55,627
+30% +$900K 0.01% 1137
2017
Q1 		$2.91M Sell
185,719
-3,426
-2% -$53.6K 0.01% 1313
2016
Q4 		$2.84M Sell
189,145
-17,720
-9% -$257K 0.01% 1276
2016
Q3 		$2.98M Sell
206,865
-12,491
-6% -$183K 0.01% 1233
2016
Q2 		$3.19M Sell
219,356
-7,229
-3% -$102K 0.01% 1083
2016
Q1 		$3.2M Sell
226,585
-3,724
-2% -$49.9K 0.01% 1046
2015
Q4 		$3.31M Buy
230,309
+2,315
+1% +$33K 0.01% 1005
2015
Q3 		$3.07M Sell
227,994
-1,471
-0.6% -$21.1K 0.01% 991
2015
Q2 		$3.41M Buy
229,465
+14,727
+7% +$224K 0.01% 1021
2015
Q1 		$3.26M Buy
214,738
+20,071
+10% +$310K 0.01% 957
2014
Q4 		$3M Buy
+194,667
New +$3.14M 0.01% 937

Other funds holding DIAX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $3.04B AUM 36.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $15.9B AUM 53.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Raymond James & Associates's DIAX Position: Q3 2024 in Review

Raymond James & Associates reduced its Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) stake by 2.3% in Q3 2024, selling an estimated $30K and leaving 88,866 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2504.

Raymond James & Associates first reported a position in DIAX in Q4 2014 and has held it in 40 quarters since. The position peaked at $6.82M in Q4 2017. 86 funds tracked by Wall St. Rank hold DIAX as of Q3 2024.

  • Raymond James & Associates held 88,866 shares of Nuveen Dow 30SM Dynamic Overwrite Fund worth $1.32M as of Q3 2024.
  • Raymond James & Associates sold 2,090 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q3 2024, an estimated $30K.
  • Nuveen Dow 30SM Dynamic Overwrite Fund made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2504 holding.
  • Raymond James & Associates first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2014 and has held it in 40 quarters since.
  • Raymond James & Associates's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $6.82M in Q4 2017.
  • 86 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.